Evidence map›Paper›PMID 35322518›Full record

ArticleBipolar disorders2022

Predictors of functional impairment in bipolar disorder: Results from 13 cohorts from seven countries by the global bipolar cohort collaborative.

Katherine E Burdick, Caitlin E Millett, Anastasia K Yocum, Cara M Altimus, Ole A Andreassen, Valerie Aubin, Raoul Belzeaux, Michael Berk, Joanna M Biernacka, Hilary P Blumberg and 40 more

Open access · bronzeAbstract read
In one paragraph

Article in Bipolar disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 4 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 4 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Clinical impact of obsessive-compulsive disorder comorbidity in bipolar disorder: a systematic review and meta-analysis.European psychiatry : the journal of the Association of European Psychiatrists · 2025
    Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. The anxious bipolar phenotype: clinical complexity and treatment response.International journal of bipolar disorders · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. The breakthrough discoveries for thriving with bipolar disorder (BDInternational journal of bipolar disorders · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors at 20 institutions in 8 countries.

Katherine E BurdickBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0003-4417-4988
Caitlin E MillettBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0003-0072-5522
Anastasia K YocumUniversity of Michigan, Ann Arbor, Michigan, USA.
Cara M AltimusThe Milken Institute, Washington, District of Columbia, USA.
Ole A AndreassenNORMENT, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Valerie AubinPôle de Psychiatrie, Centre Hospitalier Princesse Grace, Monaco, Monaco.
Raoul BelzeauxPôle de Psychiatrie, Assistance Publique Hôpitaux de Marseille, Marseille, France; INT-UMR7289, CNRS Aix-Marseille Université, Marseille, France.
Michael BerkDeakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia.
Joanna M BiernackaMayo Clinic Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-9350-4440
Hilary P BlumbergYale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-6363-4698
Anthony J CleareDepartment of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID 0000-0002-6990-939X
Claudia Diaz-ByrdUniversity of Michigan, Ann Arbor, Michigan, USA.
Caroline DubertretUniversité de Paris, INSERM UMR1266, AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU ESPRIT, service de Psychiatrie et Addictologie, Hôpital Louis Mourier, Colombes, France.
Bruno EtainUniversité de Paris, AP-HP, Groupe Hospitalo-universitaire AP-HP Nord, DMU Neurosciences, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, INSERM UMRS, Paris, France.ORCID 0000-0002-5377-1488
Lisa T EylerUniversity of California San Diego, La Jolla, CA, USA.
Brent P ForesterDivision of Geriatric Psychiatry, McLean Hospital, Belmont, MA, USA.
Janice M FullertonNeuroscience Research Australia, Sydney, Australia.ORCID 0000-0003-4014-4490
Mark A FryeMayo Clinic Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USA.
Sébastien GardPôle de Psychiatrie Générale et Universitaire, Centre Hospitalier Charles Perrens, Bordeaux, France.
Ophelia GodinUniv Paris Est Créteil, INSERM U955, IMRB, Translational Neuro-Psychiatry, Fondation FondaMental, Créteil, France.
Emmanuel HaffenClinical Psychiatry Department, Treatment-Resistant Depression Fondamental Expert Center, EA 481 Neurosciences, Bourgogne Franche Comté University, Besançon, France.
Federica KlausUniversity of California San Diego, La Jolla, CA, USA.
Trine Vik LagerbergNORMENT, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Marion LeboyerUniv Paris Est Créteil, INSERM U955, IMRB, Translational Neuro-Psychiatry, Fondation FondaMental, Créteil, France.
Anabel Martinez-AranBipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
Susan McElroySLM Lindner Center of HOPE, Mason, Ohio, USA.
Philip B MitchellSchool of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia.
Emilie OlieDepartment of Emergency Psychiatry and Acute Care, CHU Montpellier, IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, France.
Phebe OlorunfemiMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Christine PasserieuxService Hospitalo-Universitaire de psychiatrie d'adulte et d'addictologie, Centre Hospitalier de Versailles, INSERM UMR1018, DisAP-DevPsy-CESP, Université de Versailles Saint-Quentin-en-Yvelines, Université Paris-Saclay, Gif-sur-Yvette, France.
Amy T PetersMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0003-0224-647X
Daniel L PhamThe Milken Institute, Washington, District of Columbia, USA.
Mircea PolosanUniv. Grenoble Alpes, CHU de Grenoble et des Alpes, Grenoble Institut des Neurosciences (GIN) Inserm U 1216, Grenoble, France.
Julia R PotterBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-4679-0269
Martha SajatovicUniversity Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.ORCID 0000-0002-3073-668X
Ludovic SamalinCHU Clermont-Ferrand, Department of Psychiatry, University of Clermont Auvergne, UMR 6602 Institut Pascal (IP), Clermont-Ferrand, France.
Raymund SchwanUniversité de Lorraine, Inserm U 1114, Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie CPN, Laxou, France.
Megan ShanahanBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Brisa SoléBipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
Rebecca StrawbridgeDepartment of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID 0000-0002-2984-1124
Amanda L StuartDeakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia.
Ivan TorresDepartment of Psychiatry, University of British Columbia, Vancouver, Canada.
Torrill UelandNORMENT, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Eduard VietaBipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.ORCID 0000-0003-1673-8248
Lana J WilliamsDeakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia.ORCID 0000-0002-1377-1272
Anna L WrobelDeakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia.ORCID 0000-0002-1864-0394
Lakshmi N YathamDepartment of Psychiatry, University of British Columbia, Vancouver, Canada.
Allan H YoungDepartment of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Andrew A NierenbergMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0003-2897-0458
Melvin G McInnisUniversity of Michigan, Ann Arbor, Michigan, USA.
Inserm · FRBarwon Health · AUBrigham and Women's Hospital · USHarvard University · USCentro de Investigación Biomédica en Red de Salud Mental · ESKing's College London · GBOslo University Hospital · NOUniversity of Michigan · USCentre National de la Recherche Scientifique · FRMayo Clinic · USMilken Institute · USUniversity of British Columbia · CAUniversity of California San Diego · USUNSW Sydney · AUCentre Hospitalier Charles Perrens · FRFondation FondaMental · FRInstitut Pascal · FRLindner Center of HOPE · USPrincess Grace Hospital Centre · MCUniversity Hospitals of Cleveland · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
Brain-based Mechanisms of Emotion Regulation in Aging and Mood DisordersR01MH124381 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI BURDICK, KATHERINE ELIZABETH, GUNNING, FAITH M · 2021 to 2025
$4.1M
Aging and Emotion Regulation Brain Circuitry in Bipolar DisorderR01MH113230 · NIMH · YALE UNIVERSITY · PI BLUMBERG, HILARY PATRICIA · 2017 to 2021
$4.0M
Understanding the Neurocognitive Heterogeneity in Bipolar DisorderR01MH100125 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BURDICK, KATHERINE ELIZABETH · 2013 to 2017
$2.1M
Neuroinflammation and Executive Function in Bipolar Disorder: A PET-fMRI StudyK23MH122676 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI PETERS, AMY · 2021 to 2025
$999k
MHealth Monitoring of Acoustic and Behavioral Patterns in Bipolar Disorder Across CulturesR21MH114835 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MCINNIS, MELVIN G · 2017 to 2018
$332k
NCATS NIH HHS UL1 TR001863NCATS NIH HHS UL1 TR002240NIMH NIH HHS K23 MH122676NIMH NIH HHS R01 MH100125NIMH NIH HHS R01 MH113230NIMH NIH HHS R01 MH124381NIMH NIH HHS R21 MH114835Wellcome Trust
6 · The paper itself

Abstract

objectivesPersistent functional impairment is common in bipolar disorder (BD) and is influenced by a number of demographic, clinical, and cognitive features. The goal of this project was to estimate and compare the influence of key factors on community function in multiple cohorts of well-characterized samples of individuals with BD.

methodsThirteen cohorts from 7 countries included n = 5882 individuals with BD across multiple sites. The statistical approach consisted of a systematic uniform application of analyses across sites. Each site performed a logistic regression analysis with empirically derived "higher versus lower function" as the dependent variable and selected clinical and demographic variables as predictors.

resultsWe found high rates of functional impairment, ranging from 41 to 75%. Lower community functioning was associated with depressive symptoms in 10 of 12 of the cohorts that included this variable in the analysis. Lower levels of education, a greater number of prior mood episodes, the presence of a comorbid substance use disorder, and a greater total number of psychotropic medications were also associated with low functioning.

conclusionsThe bipolar clinical research community is poised to work together to characterize the multi-dimensional contributors to impairment and address the barriers that impede patients' complete recovery. We must also identify the core features which enable many to thrive and live successfully with BD. A large-scale, worldwide, prospective longitudinal study focused squarely on BD and its heterogeneous presentations will serve as a platform for discovery and promote major advances toward optimizing outcomes for every individual with this illness.

Indexed as

Bipolar DisorderAffectCohort StudiesHumansLongitudinal StudiesProspective Studies

Identifiers

PMID35322518
PMCPMC9500115
OpenAlexW4220883910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.